Investigating glatiramer acetate for relapsing–remitting multiple sclerosis at the double dose—is more better?

被引：0
|
作者：
Peter A Calabresi
机构：
[1] PA Calabresi is Associate Professor of Neurology and Director of the Johns Hopkins Multiple Sclerosis Center,
[2] Baltimore,undefined
[3] MD,undefined
[4] USA.,undefined
来源：
Nature Clinical Practice Neurology | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：540 / 541
页数：1
相关论文
共 50 条
  • [1] Investigating glatiramer acetate for relapsing-remitting multiple sclerosis at the double dose - is more better?
    Calabresi, Peter A.
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (10): : 540 - 541
  • [2] Glatiramer acetate: Promise in relapsing-remitting multiple sclerosis?
    不详
    [J]. Drugs & Therapy Perspectives, 1998, 11 (10) : 1 - 5
  • [3] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
  • [4] Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
    Dene Simpson
    Stuart Noble
    Caroline Perry
    [J]. BioDrugs, 2003, 17 : 207 - 210
  • [5] Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis
    Simpson, D
    Noble, S
    Perry, C
    [J]. BIODRUGS, 2003, 17 (03) : 207 - 210
  • [6] Glatiramer acetate - A review of its use in relapsing-remitting multiple sclerosis
    Simpson, D
    Noble, S
    Perry, C
    [J]. CNS DRUGS, 2002, 16 (12) : 825 - 850
  • [7] Erythema nodosum and glatiramer acetate treatment in relapsing-remitting multiple sclerosis
    Thouvenot, E.
    Hillaire-Buys, D.
    Bos-Thompson, M. A.
    Rigau, V.
    Durand, L.
    Guillot, B.
    Camu, W.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (07) : 941 - 944
  • [8] Glatiramer Acetate 40 mg/mL in Relapsing–Remitting Multiple Sclerosis: A Review
    Kate McKeage
    [J]. CNS Drugs, 2015, 29 : 425 - 432
  • [9] Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis
    Earnshaw, Stephanie
    Graham, Jonathan
    Oleen-Burkey, MerriKay
    Castelli-Haley, Jane
    Johnson, Kenneth
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2009, 7 (02) : 91 - 108
  • [10] Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis
    Stephanie R. Earnshaw
    Jonathan Graham
    MerriKay Oleen-Burkey
    Jane Castelli-Haley
    Kenneth Johnson
    [J]. Applied Health Economics and Health Policy, 2009, 7 (2) : 91 - 108
12345